Vycor Medical (VYCO) EBITDA Margin Growth (1y) (2011 - 2026)
Vycor Medical (VYCO) EBITDA Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -313.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 535.00 |
| 10 | Vycor Medical | - | - | 375,153.00 | 1,322.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,322.00 |
| Dec 31, 2025 | -1,356.00 |
| Sep 30, 2025 | 1,626.00 |
| Jun 30, 2025 | 728.00 |
| Mar 31, 2025 | 25.00 |
| Dec 31, 2024 | 2,871.00 |
| Sep 30, 2024 | 152.00 |
| Jun 30, 2024 | -1,664.00 |
| Mar 31, 2024 | -1,098.00 |
| Dec 31, 2023 | 1,278.00 |
| Sep 30, 2023 | 2,022.00 |
| Jun 30, 2023 | 4,436.00 |
| Mar 31, 2023 | 2,566.00 |
| Dec 31, 2022 | 2,538.00 |
| Sep 30, 2022 | -3,815.00 |
| Jun 30, 2022 | -2,828.00 |
| Mar 31, 2022 | 5,838.00 |
| Dec 31, 2021 | 37.00 |
| Sep 30, 2021 | 7,297.00 |
| Jun 30, 2021 | 9,998.00 |